Cargando…

Serum prednisolone levels as a marker of oral corticosteroid adherence in severe asthma

BACKGROUND: Severe asthma is a complex heterogeneous disease typically requiring advanced therapies. Underlying the treatment of all asthma, however, is the consistent recommendation across international guidelines to ensure that adherence to therapy is adequate. Currently, there is no consensus on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ramsahai, J. Michael, King, Emily, Niven, Robert, Tavernier, Gael, Wark, Peter A. B., Simpson, Jodie L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7451116/ https://www.ncbi.nlm.nih.gov/pubmed/32854657 http://dx.doi.org/10.1186/s12890-020-01263-y

Ejemplares similares

Eosinophilia as a treatable trait in three patients with asthma and COPD
por: Ramsahai, James Michael, et al.
Publicado: (2018)

A survey of specialist opinions on biomarker use in severe asthma in Australia: scepticism but hope?
por: Ramsahai, J. Michael, et al.
Publicado: (2020)

Oral Corticosteroids Tapering in Severe Asthma
por: Boulet, Louis-Philippe, et al.
Publicado: (2021)

Blood neutrophil activation markers in severe asthma: lack of inhibition by prednisolone therapy
por: Mann, Bhupinder S, et al.
Publicado: (2006)

Effectiveness of oral corticosteroids (prednisolone) in sensorineural hearing loss post COVID-19
por: Essawy, Wessam Mostafa
Publicado: (2022)

Assessment of adherence to corticosteroids in asthma by drug monitoring or fractional exhaled nitric oxide: A literature review
por: Alahmadi, Fahad, et al.
Publicado: (2020)

Prevalence of oral corticosteroid use in the German severe asthma population
por: Taube, Christian, et al.
Publicado: (2019)

Hemopexin: A Novel Anti-inflammatory Marker for Distinguishing COPD From Asthma
por: Winter, Natasha A., et al.
Publicado: (2021)

Development of oral dispersible tablets containing prednisolone nanoparticles for the management of pediatric asthma
por: Chen, Yi-Dan, et al.
Publicado: (2015)

Methotrexate as an oral corticosteroid-sparing agent in severe asthma: the emergence of a responder asthma endotype
por: Knarborg, Malene, et al.
Publicado: (2014)

Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI)
por: Canonica, Giorgio Walter, et al.
Publicado: (2020)

Long-term adherence to inhaled corticosteroids and asthma control in adult-onset asthma
por: Vähätalo, Iida, et al.
Publicado: (2021)

Non-adherence to inhaled corticosteroids and the risk of asthma exacerbations in children
por: Vasbinder, Erwin C, et al.
Publicado: (2016)

12-year adherence to inhaled corticosteroids in adult-onset asthma
por: Vähätalo, Iida, et al.
Publicado: (2020)

A trial of oral corticosteroids for persistent systemic and airway inflammation in severe asthma
por: Oishi, Keiji, et al.
Publicado: (2017)

Rational oral corticosteroid use in adult severe asthma: A narrative review
por: Chung, Li Ping, et al.
Publicado: (2019)

Long-term efficacy of dupilumab in severe asthma by baseline oral corticosteroid dose
por: Domingo, Christian, et al.
Publicado: (2023)

Assessing Adherence to Inhaled Corticosteroids Among Adults with Asthma in Kuwait Using the Medication Adherence Report Scale for Asthma
por: Albassam, Abdullah, et al.
Publicado: (2020)

Oral corticosteroid prescription patterns for asthma in France, Germany, Italy and the UK
por: Tran, Trung N., et al.
Publicado: (2020)

Mepolizumab asthma treatment failure due to refractory airway eosinophilia, which responded to benralizumab
por: Cook, Alistair, et al.
Publicado: (2021)

Climate Change to Blame in Severe Oral Corticosteroid-Dependent Asthma? A Case Report
por: Huang, Chunrong, et al.
Publicado: (2020)

Oral Corticosteroid Reduction Between Biologics Initiated and Non-Initiated Patients with Severe Asthma
por: Tanaka, Akihiko, et al.
Publicado: (2023)

High degree of supervision improves adherence to inhaled corticosteroids in children with asthma
por: Park, Geun Mi, et al.
Publicado: (2015)

Self-reported vs. objectively assessed adherence to inhaled corticosteroids in asthma
por: Jensen, Frodi Fridason, et al.
Publicado: (2021)

Risk Factors for Non-Adherence to Inhaled Corticosteroids in Preschool Children with Asthma
por: Bach, Louise Mandrup, et al.
Publicado: (2022)

Comparative effectiveness of oral dexamethasone vs. oral prednisolone for acute exacerbation of asthma: A randomized control trial
por: Banoth, Bhaskar, et al.
Publicado: (2022)

cFLIP expression is altered in severe corticosteroid-resistant asthma
por: Lazarev, Dennis, et al.
Publicado: (2014)

Chronic oral corticosteroids use and persistent eosinophilia in severe asthmatics from the Belgian severe asthma registry
por: Graff, S., et al.
Publicado: (2020)

Pharmacokinetics of Orally Administered Prednisolone in Alpacas
por: Videla, Ricardo, et al.
Publicado: (2021)

Airway β-Defensin-1 Protein Is Elevated in COPD and Severe Asthma
por: Baines, Katherine J., et al.
Publicado: (2015)

Differential serum protein markers and the clinical severity of asthma
por: Meyer, Norbert, et al.
Publicado: (2014)

Trends in oral corticosteroids use in severe asthma: a 14-year population-based study
por: Sadatsafavi, Mohsen, et al.
Publicado: (2021)

Real-World Reductions in Oral Corticosteroid Use in the USA Following Mepolizumab Therapy for Severe Asthma
por: Silver, Jared, et al.
Publicado: (2020)

Adherence to inhaled corticosteroids in relation to quality of life and symptoms of anxiety and depression in asthma
por: Renzi-Lomholt, Martino, et al.
Publicado: (2022)

Adherence to inhaled corticosteroids in patients with asthma prior to and during the COVID-19 pandemic
por: Rodríguez, Isabel, et al.
Publicado: (2023)

Blood Eosinophil Depletion with Mepolizumab, Benralizumab, and Prednisolone in Eosinophilic Asthma
por: Moran, Angela M., et al.
Publicado: (2020)

Effectiveness of single dose oral dexamethasone versus multidose prednisolone for treatment of acute exacerbations of asthma among children
por: Tayyab, Asma, et al.
Publicado: (2022)

Six gene and TH2 signature expression in endobronchial biopsies of participants with asthma
por: Sánchez‐Ovando, Stephany, et al.
Publicado: (2020)

Asthma and Therapeutics: Inhaled Corticosteroids, Corticosteroid Osteoporosis, and the Risk of Fracture in Chronic Asthma
por: Toogood, John H
Publicado: (2005)

Using biomarkers to adjust corticosteroid dose in patients with severe asthma
por: Jones, Thomas L.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p5bj3o60blg6tofkbnbc56v27c